Overcoming barriers to implementing precision dosing with 5‐fluorouracil and capecitabine-Reference-Cited by-同舟云学术

Overcoming barriers to implementing precision dosing with 5‐fluorouracil and capecitabine

Published:2021-01-15 Issue:2 Volume:87 Page:317-325
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Schneider Jennifer J.¹²^ORCID,Galettis Peter¹²^ORCID,Martin Jennifer H.¹²^ORCID

Affiliation:

1. Discipline of Clinical Pharmacology, School of Medicine and Public Health University of Newcastle Newcastle New South Wales Australia

2. Centre for Drug Repurposing and Medicines Research Level 3 Hunter Medical Research Institute Kookaburra Circuit Newcastle New South Wales Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14723

Reference77 articles.

1. A review on the importance of genotyping and phenotyping in fluoropyrimidine treatment;Deac AL;Med Pharm Rep,2020

2. Essential medicines for cancer: WHO recommendations and national priorities

3. Capecitabine: an overview of the side effects and their management

4. Therapeutic drug monitoring of 5-fluorouracil

5. Body-Surface Area–Based Chemotherapy Dosing: Appropriate in the 21st Century?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus;British Journal of Clinical Pharmacology;2024-04-16

2. Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors;Pharmacology Research & Perspectives;2024-03

3. Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity;The Pharmacogenomics Journal;2024-01-12

4. Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review;Therapeutic Advances in Medical Oncology;2024-01

5. Crystal Structure of DNA Replication Protein SsbA Complexed with the Anticancer Drug 5-Fluorouracil;International Journal of Molecular Sciences;2023-10-04